Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides. (Q54541037)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides. |
scientific article |
Statements
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides. (English)
Johannes Müthing
Monika Burg
Babette Möckel
Martin Langer
Wolfgang Metelmann-Strupat
Andreas Werner
Ulrich Neumann
Jasna Peter-Katalinic
Jürgen Eck
1 August 2002
12
8
485-497